NEW YORK, Oct. 19, 2022 (GLOBE NEWSWIRE) — Kenneth Research has published an in-depth market report on “Global auto injectors market‘ for the forecast period, i.e. 2022 – 2031, which includes the following factors:
- Market growth over the forecast period
- Detailed regional summary
- market segmentation
- Growth drivers and challenges
- Profiling of key market players
Global auto injectors Market size:
The global auto-injectors market is estimated to grow at a CAGR of ~18% during the forecast period i.e. 2022-2031. Additionally, the market recorded revenue of approximately $54.0 billion in 2021. The market can be attributed to the benefits of the auto-injectors in the form of reduced risk of needle injuries, reduction in needle-related phobia, proper dosage assurance, and others. According to the World Health Organization, asthma affected approximately 262 million people in 2019 and was responsible for 461,000 deaths. In addition, auto-injectors are used to treat a wide range of chronic disease symptoms, including asthma, and can even be used by the patient in an emergency. Therefore, the ease of use and other advantages are expected to drive the growth of the global auto injector market.
Get a sample copy of this report @ https://www.kennethresearch.com/sample-request-10094781
Global auto injectors Market: The central theses
- The North America region is expected to generate the largest share of sales by 2031
- The hospital segment dominates the revenue chart
- The diabetes segment remains prominent in the purpose segment
Rising Cases Of Diabetes Across The World To Boost Market Growth
COVID-19 has had a positive impact on the global auto injector market. The impact of COVID-19 has been widespread and patients have been asked to postpone their non-essential treatments due to government restrictions. The healthcare infrastructure has not been able to meet patient demand due to the high proportion of the population affected by the pandemic. Additionally,…
